Bulawit, Eva Mae N.
HRN: 22-80-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2023
CEFUROXIME 1.5GM (VIAL)
05/12/2023
05/12/2023
IVT
1.5g
On Call To OR
For CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes